Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-16

FDA Approved: RESTORIL — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for RESTORIL (temazepam) submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RESTORIL (temazepam)

Snippet

SUPPL AP for RESTORIL (TEMAZEPAM)